Retrograde study showed a mitral-valve gradient of 25 mm. of mercury, a calculated forward-valve area of 0.3 square centimeter and an elevated pulmonary arteriolar resistance. An angiocardiogram (Fig.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results